Proquility Private Wealth Partners LLC Sells 875 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Proquility Private Wealth Partners LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 12.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,297 shares of the healthcare conglomerate’s stock after selling 875 shares during the quarter. UnitedHealth Group comprises 1.3% of Proquility Private Wealth Partners LLC’s investment portfolio, making the stock its 25th biggest holding. Proquility Private Wealth Partners LLC’s holdings in UnitedHealth Group were worth $3,315,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Richelieu Gestion SA acquired a new position in UnitedHealth Group during the 4th quarter valued at about $26,000. CGC Financial Services LLC raised its position in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 50 shares during the last quarter. LFA Lugano Financial Advisors SA boosted its holdings in UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares during the last quarter. O Brien Wealth Partners LLC lifted its position in shares of UnitedHealth Group by 36.8% during the fourth quarter. O Brien Wealth Partners LLC now owns 78 shares of the healthcare conglomerate’s stock valued at $41,000 after purchasing an additional 21 shares in the last quarter. Finally, Friedenthal Financial bought a new stake in UnitedHealth Group in the 4th quarter worth about $42,000. 87.86% of the stock is owned by institutional investors.

Insider Activity

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Price Performance

UNH traded down $8.66 on Monday, reaching $508.17. The company had a trading volume of 2,528,200 shares, compared to its average volume of 4,169,015. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The company has a market cap of $467.71 billion, a price-to-earnings ratio of 31.06, a P/E/G ratio of 1.47 and a beta of 0.55. The business has a 50 day simple moving average of $489.65 and a 200 day simple moving average of $510.33.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s revenue was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.26 earnings per share. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on UNH. Bank of America reaffirmed a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. Truist Financial restated a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Royal Bank of Canada dropped their target price on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Monday, May 13th. Finally, Piper Sandler raised their target price on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Three research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $570.05.

Get Our Latest Stock Report on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.